Chiara Romagnoli

577 total citations
15 papers, 474 citations indexed

About

Chiara Romagnoli is a scholar working on Molecular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Chiara Romagnoli has authored 15 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Medicine, 8 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Chiara Romagnoli's work include Antibiotic Resistance in Bacteria (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Click Chemistry and Applications (2 papers). Chiara Romagnoli is often cited by papers focused on Antibiotic Resistance in Bacteria (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Click Chemistry and Applications (2 papers). Chiara Romagnoli collaborates with scholars based in Italy, United States and France. Chiara Romagnoli's co-authors include Fabio Prati, Emilia Caselli, Robert A. Bonomo, Magdalena A. Taracila, Richard Bonnet, Brian K. Shoichet, O. Eidam, Guillaume Dalmasso, Christopher R. Bethel and Laura J. Rojas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Gut.

In The Last Decade

Chiara Romagnoli

15 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Romagnoli Italy 12 263 241 131 118 110 15 474
Patricia Lassaux Belgium 15 392 1.5× 259 1.1× 237 1.8× 148 1.3× 160 1.5× 20 781
Sara López Spain 13 256 1.0× 190 0.8× 94 0.7× 181 1.5× 156 1.4× 21 579
Anjaneyulu Sheri United States 14 179 0.7× 118 0.5× 132 1.0× 45 0.4× 110 1.0× 21 417
Karina Calvopiña United Kingdom 13 361 1.4× 169 0.7× 129 1.0× 51 0.4× 158 1.4× 21 484
Paola Dozzo United States 9 191 0.7× 182 0.8× 54 0.4× 107 0.9× 133 1.2× 10 446
Mahesh Aitha United States 12 371 1.4× 178 0.7× 107 0.8× 26 0.2× 154 1.4× 19 515
Malgosia Kania Switzerland 10 326 1.2× 219 0.9× 96 0.7× 84 0.7× 236 2.1× 12 614
Michele Johnstone United States 10 540 2.1× 229 1.0× 152 1.2× 53 0.4× 325 3.0× 13 738
María‐Natalia Lisa France 11 227 0.9× 276 1.1× 105 0.8× 22 0.2× 94 0.9× 25 556
Alexey Bulychev United States 13 241 0.9× 185 0.8× 54 0.4× 64 0.5× 135 1.2× 15 409

Countries citing papers authored by Chiara Romagnoli

Since Specialization
Citations

This map shows the geographic impact of Chiara Romagnoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Romagnoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Romagnoli more than expected).

Fields of papers citing papers by Chiara Romagnoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Romagnoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Romagnoli. The network helps show where Chiara Romagnoli may publish in the future.

Co-authorship network of co-authors of Chiara Romagnoli

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Romagnoli. A scholar is included among the top collaborators of Chiara Romagnoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Romagnoli. Chiara Romagnoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Caselli, Emilia, Chiara Romagnoli, R.A. Powers, et al.. (2017). Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors. ACS Infectious Diseases. 4(3). 337–348. 26 indexed citations
2.
Taracila, Magdalena A., Chiara Romagnoli, Emilia Caselli, et al.. (2017). Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase. ACS Infectious Diseases. 4(3). 325–336. 28 indexed citations
3.
Nguyen, Nhu Q., Nikhil Krishnan, Laura J. Rojas, et al.. (2016). Crystal Structures of KPC-2 and SHV-1 β-Lactamases in Complex with the Boronic Acid Transition State Analog S02030. Antimicrobial Agents and Chemotherapy. 60(3). 1760–1766. 33 indexed citations
4.
Rojas, Laura J., Magdalena A. Taracila, Krisztina M. Papp‐Wallace, et al.. (2016). Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design. Antimicrobial Agents and Chemotherapy. 60(3). 1751–1759. 50 indexed citations
5.
Romagnoli, Chiara, et al.. (2015). Synthesis, characterization and metal coordination of a potential β-lactamase inhibitor: 5-Methyl-2-phenoxymethyl-3- H -imidazole-4-carboxylic acid (PIMA). Arabian Journal of Chemistry. 10(8). 1061–1069. 2 indexed citations
6.
Caselli, Emilia, et al.. (2015). Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors. Journal of Medicinal Chemistry. 58(14). 5445–5458. 36 indexed citations
7.
Romagnoli, Chiara, Emilia Caselli, & Fabio Prati. (2015). Synthesis of [(1,2,3‐Triazol‐1‐yl)methyl]boronic Acids Through Click Chemistry: Easy Access to a Potential Scaffold for Protease Inhibitors. European Journal of Organic Chemistry. 2015(5). 1075–1083. 11 indexed citations
8.
Cougnoux, Antony, Julien Delmas, Lucie Gibold, et al.. (2015). Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria. Gut. 65(2). 278–285. 66 indexed citations
9.
Kurz, Sebastian G., Saugata Hazra, Christopher R. Bethel, et al.. (2015). Inhibiting the β-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs). ACS Infectious Diseases. 1(6). 234–242. 26 indexed citations
10.
Powers, R.A., Magdalena A. Taracila, Chiara Romagnoli, et al.. (2014). Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii. Biochemistry. 53(48). 7670–7679. 32 indexed citations
11.
D’Annibale, Andrea, Maurizio D’Auria, Fabio Prati, et al.. (2013). Paternò–Büchi reaction versus hydrogen abstraction in the photochemical reactivity of alkenyl boronates with benzophenone. Tetrahedron. 69(19). 3782–3795. 6 indexed citations
12.
Prati, Fabio, et al.. (2013). Sulfonamido-substituted boronic acids as β-lactamase inhibitors for treatment of antibiotic-resistant bacterial infections. 1 indexed citations
13.
Winkler, Marisa, Magdalena A. Taracila, Sarah M. Drawz, et al.. (2012). Design and Exploration of Novel Boronic Acid Inhibitors Reveals Important Interactions with a Clavulanic Acid-Resistant Sulfhydryl-Variable (SHV) β-Lactamase. Journal of Medicinal Chemistry. 56(3). 1084–1097. 39 indexed citations
14.
Eidam, O., Chiara Romagnoli, Guillaume Dalmasso, et al.. (2012). Fragment-guided design of subnanomolar β-lactamase inhibitors active in vivo. Proceedings of the National Academy of Sciences. 109(43). 17448–17453. 62 indexed citations
15.
Eidam, O., Chiara Romagnoli, Emilia Caselli, et al.. (2010). Design, Synthesis, Crystal Structures, and Antimicrobial Activity of Sulfonamide Boronic Acids as β-Lactamase Inhibitors. Journal of Medicinal Chemistry. 53(21). 7852–7863. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026